about
Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activationThe mechanism underlying activation of factor IX by factor XIa.Glycosaminoglycan-binding properties and kinetic characterization of human heparin cofactor II expressed in Escherichia coliSucrose octasulfate selectively accelerates thrombin inactivation by heparin cofactor IIRapid binding of plasminogen to streptokinase in a catalytic complex reveals a three-step mechanism.Activation of factor XI by products of prothrombin activationFluorescent reporters of thrombin, heparin cofactor II, and heparin binding in a ternary complex.A sequential mechanism for exosite-mediated factor IX activation by factor XIaBinding of the COOH-terminal lysine residue of streptokinase to plasmin(ogen) kringles enhances formation of the streptokinase.plasmin(ogen) catalytic complexes.Role of the streptokinase alpha-domain in the interactions of streptokinase with plasminogen and plasminExosite-mediated substrate recognition of factor IX by factor XIa. The factor XIa heavy chain is required for initial recognition of factor IX.The dimeric structure of factor XI and zymogen activationCharacterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation.Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibitionThe hyperglycemic byproduct methylglyoxal impairs anticoagulant activity through covalent adduction of antithrombin III.A novel antithrombin domain dictates the journey's end of a proteinase.Rapid-reaction kinetic characterization of the pathway of streptokinase-plasmin catalytic complex formation.Resolution of conformational activation in the kinetic mechanism of plasminogen activation by streptokinase.An update on factor XI structure and function.Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation.Proteases: Pivot Points in Functional ProteomicsThe preferred pathway of glycosaminoglycan-accelerated inactivation of thrombin by heparin cofactor IIBinding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II
P50
Q27642265-6A34EDE3-E8EC-40CE-B6AB-B359B08F8453Q33597260-563F0B3D-1EF0-4860-A21D-46D79B5C9D91Q33645142-EE740388-7851-4F7A-B1F6-BA5FF529D794Q33707130-E7FE205D-E2FC-420C-B719-999020E7F099Q34283594-7E6C4317-5E56-49BB-9D2C-905099F31D50Q35112259-4071C2DD-ECDD-4C35-8306-8AE70F8B3727Q36288526-242E325C-8ED7-4421-BCDE-DA2B5756CF8BQ36368312-C090E3A9-17F0-409D-A2AD-30D559BA44BEQ36536357-B1CC2F47-1232-4725-BCAD-E1D763212FA5Q36538510-3D74767F-1487-49BB-97BF-5DA1BC1CB40EQ36538521-73CF2A1B-E28B-40B1-85BB-8507794907A8Q36833564-2D7A76EA-8D42-4D28-A451-3C501DFD2F5DQ37078887-75EC7E6D-B6B6-4FCB-AB35-8AF19E05FF68Q41790954-510A6B71-6C2E-411E-A10B-E798C211F95CQ41910544-5E0419D8-374C-49B8-9A24-F584A73E7476Q42070359-2F167761-1588-4F19-850C-E999EDF177F6Q42458195-AC79D758-5A71-4E48-9443-9B3D090FE943Q44950428-9C24C329-0E1B-4774-A952-21EFFA208D08Q47311661-64EE4184-25EB-44B3-A700-BCC1A2E27260Q50961053-EE49E498-6BB0-48BE-9357-C1BFDEFE1C66Q57022956-F07C1A3E-45E2-44F6-A3C0-6E47C596216AQ75216773-19A7ECD8-578E-43F1-82BB-87087FABAF24Q77296407-440726FE-E283-409A-AAED-59FF386DA68A
P50
description
pathologist
@en
name
Ingrid M. Verhamme
@en
type
label
Ingrid M. Verhamme
@en
prefLabel
Ingrid M. Verhamme
@en